ErbB- and MUC1-targeted CAR-T cell immunotherapy of oral squamous cell carcinoma
Chimeric antigen receptor T (CAR-T) cell therapy has shown great success in treating B cell malignancies; however, there are many challenges that limit their therapeutic efficacy in solid tumours. Immunotherapy of head and neck squamous cell carcinoma (HNSCC), and, in particular, oral squamous cell...
Saved in:
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-03-01
|
Series: | Frontiers in Dental Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fdmed.2023.1116402/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|